Comparative Effectiveness of Antipsychotic Drugs for Rehospitalization in Schizophrenia—A Nationwide Study With 20-Year Follow-up

Real-World Effectiveness of Antipsychotic Treatments in a Nationwide Cohort of 29 823 Patients With Schizophrenia

(2017) Jari Tiihonen et al.   JAMA Psychiatry

Comparative effectiveness and safety of antipsychotic drugs in schizophrenia treatment: a real-world observational study

(2016) A. Vanasse et al.   ACTA PSYCHIATRICA SCANDINAVICA

The Societal Cost of Schizophrenia: A Systematic Review

(2016) Huajie Jin et al.   PHARMACOECONOMICS

The incidence of schizophrenia and schizophrenia spectrum disorders in Denmark in the period 2000–2012. A register-based study

(2016) Johanne Olivia Grønne Kühl et al.   SCHIZOPHRENIA RESEARCH

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons

(2016) Heidi Taipale et al.   Clinical Epidemiology

From prescription drug purchases to drug use periods – a second generation method (PRE2DUP)

(2015) Antti Tanskanen et al.   BMC Medical Informatics and Decision Making

The Effect of Clozapine on Premature Mortality: An Assessment of Clinical Monitoring and Other Potential Confounders

(2014) R. D. Hayes et al.   SCHIZOPHRENIA BULLETIN

Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis

(2013) Stefan Leucht et al.   LANCET

Antipsychotics and mortality in first-onset schizophrenia: Prospective Finnish register study with 5-year follow-up

(2013) Marjo Kiviniemi et al.   SCHIZOPHRENIA RESEARCH

A Nationwide Cohort Study of Oral and Depot Antipsychotics After First Hospitalization for Schizophrenia

(2011) Jari Tiihonen et al.   AMERICAN JOURNAL OF PSYCHIATRY

11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)

(2009) Jari Tiihonen et al.   LANCET